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Vibrio vulnificus is a Gram-negative bacterium that causes a fatal septicemia. One of its virulence factors is
a membrane-bound lipoprotein, IlpA, which can induce cytokine production in human immune cells. In the
present study, the role of IlpA as an adhesion molecule was investigated. An ilpA-deleted V. vulnificus mutant
showed significantly decreased adherence to INT-407 human intestinal epithelial cells, which in turn resulted
in reduced cytotoxicity. The ilpA mutant recovered the adherence ability of the wild type by complementation
in trans with the intact ilpA gene. In addition, pretreatment of V. vulnificus with anti-IlpA polyclonal antibodies
resulted in a significant reduction of bacterial adherence. To localize the domain of IlpA required for
cytoadherence, three truncated recombinant IlpA polypeptides were constructed and tested for the ability to
adhere to human cells by a ligand-binding immunoblot assay and fluorescence microscopy. The polypeptide
containing the carboxy (C)-terminal hydrophilic domain exhibited direct binding to INT-407 cells. Therefore,
the C-terminal domain of IlpA allows this protein to be an adhesion molecule of V. vulnificus.
Vibrio vulnificus is a Gram-negative pathogenic bacterium
that is encapsulated, motile, and invasive. This pathogen is
frequently associated with primary septicemia following the con-
sumption of contaminated shellfish. Over 50% of patients with V.
vulnificus-induced septicemia die due to multiorgan failure as a
result of rapidly progressive shock syndrome (3, 19).
Diverse virulence factors have been proposed for V. vulnifi-
cus. Based on the attenuated mouse lethality of V. vulnificus
mutants deficient in capsular polysaccharide (CPS) or exopoly-
saccharides (EPS), these molecules have been shown to be
important for V. vulnificus pathogenesis (18, 38). Type IV pilin
was confirmed to be involved in the virulence of V. vulnificus
via genetic deletion of its structural gene, pilA (26, 27). In
addition, motility was also discovered to be a critical virulence
determinant of V. vulnificus (21). Secreted proteins, such as a
cytolytic hemolysin (37) and an elastase (24), have been pro-
posed to cause damage to host tissues, but in vivo studies using
a knockout V. vulnificus mutant of vvhA (cytolysis gene) or
vvpE (elastase gene) did not convincingly demonstrate that
these proteins are key virulence factors causing lethality in
mice or lysis of human cells (11, 30, 36).
The initial stage of microbial infection of host cells is medi-
ated by interactions of the surface proteins of the pathogen
with the connective tissues or epithelial cells of the host to
facilitate bacterial adherence and/or to elicit signal transduc-
tion within host cells (5). For example, the most abundant
outer membrane protein (OMP) of V. vulnificus, OmpU, has
been identified to be involved in interactions with host extra-
cellular matrix proteins, such as fibronectin (7). Knockout mu-
tagenesis of the ompU gene results in the loss of cytoadherence
as well as in decreased bacterial toxicity toward epithelial cells
and mice. Membrane-bound IlpA lipoprotein was also identi-
fied to interact with host cells via stimulating the production of
proinflammatory cytokines in human monocytes via Toll-like
receptor 2 (TLR2). Lipid moieties attached to the N-terminal
end of the processed IlpA protein are required for cytokine
production (8). Subsequent investigation of V. vulnificus IlpA
in this study showed that this protein is also important in
bacterial adherence to human cell lines. Thus, we further iden-
tified the region of IlpA required for adherence to human cells.
MATERIALS AND METHODS
Strains, plasmids, and bacterial cultivation. The strains and plasmids used in
this study are listed in Table 1. Escherichia coli was grown at 37°C in Luria-
Bertani (LB) broth (1% [wt/vol] tryptone, 0.5% [wt/vol] yeast extract, 1% [wt/vol]
NaCl, pH 7.5) supplemented with ampicillin at 100 g/ml for the maintenance of
plasmids. Various strains of V. vulnificus were cultured in LBS broth (1% [wt/vol]
tryptone, 0.5% [wt/vol] yeast extract, 2% [wt/vol] NaCl, pH 7.5) at 30°C with
tetracycline (2 g/ml) when needed. All medium components were purchased
from Difco, and the chemicals and antibiotics were obtained from Sigma.
Construction of a plasmid expressing a truncated form of IlpA lacking the C
terminus. A plasmid, pilpA[1-169], was constructed to express a mutated recom-
binant IlpA (rIlpA) polypeptide in which 99 amino acids at the C terminus were
missing. The ilpA DNA fragment of 729 bp, which encodes amino acid residues
from the N terminus to the 169th amino acid of IlpA, was amplified from the
genomic DNA of wild-type V. vulnificus by a PCR using the primers ilpA-comF
(5-GGTTGGATCCATTGGTGAGCT-3; the underlined sequence denotes a
BamHI restriction site) and ilpA170-CR (5-CCCAAGCTTTCAGTCACGA
ACGGTCGCAAGTAG-3; the underlined sequence indicates a HindIII restric-
tion site), digested with BamHI and HindIII, and then cloned into the broad-
host-range plasmid pLAFR5. The resultant plasmid, pilpA[1-169], was
transformed into E. coli SM10 pir and then transferred into the V. vulnificus ilpA
mutant by conjugation. The exconjugants were selected on thiosulfate-citrate-
bile-sucrose agar containing tetracycline (2 g/ml). Expression of the truncated
polypeptide in the ilpA mutant was examined by Western blotting using anti-
IlpA polyclonal antibodies.
Cell line adherence assay. Adherence assays were performed with the INT-407
cell line, which is derived from human intestinal epithelial cells (ATCC CCL-6),
in 24-well culture plates. Each well of the culture plates was seeded with 2  105
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INT-407 cells and incubated overnight at 37°C in the presence of 5% CO2. After
removal of the medium and two washes with phosphate-buffered saline (PBS;
137 mM NaCl, 2.7 mM KCl, 10.1 mM Na2HPO4, and 2 mM KH2PO4, pH 7.3),
1 ml of serum-free Dulbecco’s modified Eagle medium (DMEM; Gibco-BRL)
was added to the INT-407 cells. Various V. vulnificus strains (ATCC 29307
harboring pLAFR5, YS101 carrying pLAFR5, YS101 carrying pLAFR-ilpA [8],
and YS101 carrying pilpA[1-169]) were grown at 30°C in LBS broth with 2 g/ml
tetracycline. At an optical density at 600 nm (OD600) of 0.7, 1 mM IPTG
(isopropyl--D-thiogalactopyranoside) was added to the bacterial cultures, and
they were incubated for another 3 h at 30°C before being used for cytoadherence
assays. Cell monolayers were inoculated in triplicate with 50 l of the diluted
bacteria to give a multiplicity of infection (MOI) of 10 and were incubated at
37°C in 5% CO2 for 30 min. While V. vulnificus shows similar growth rates and
maximum yields for growth at 30 and 37°C, INT-407 cells exhibit optimal growth
at 37°C. Thus, the assays including both V. vulnificus and INT-407 cells were
performed at 37°C. The monolayer was washed five times with prewarmed PBS
to remove nonadherent bacteria. Following the last wash, the INT-407 cells were
lysed with 0.1% Triton X-100 for 15 min. The bacteria were recovered from these
cells with PBS, serially diluted 10-fold, and then plated on LBS agar.
Adherence-blocking experiments with anti-IlpA antibodies. Prior to cytoad-
herence assays, 1  108 cells of V. vulnificus were preincubated with anti-IlpA
antibodies (8) for 1 h at various concentrations ranging from 10 to 30 g/ml.
Preimmune rat serum was used as a control immunoglobulin (IgG) to monitor
the nonspecific effect of serum on the binding of V. vulnificus to INT-407 cells.
Cytotoxicity assays. The cytotoxicity of V. vulnificus toward INT-407 cells was
measured using a CytoTox 96 nonradioactive cytotoxicity assay kit (Promega).
This cytotoxicity kit measures the lactate dehydrogenase (LDH) activity released
into the culture medium by lysed INT-407 cells. To measure the total LDH
activity of the cell lines used in the assays, Triton X-100 was added to a final
concentration of 1.0% (vol/vol) to lyse the host cells. Various V. vulnificus strains
(ATCC 29307 harboring pLAFR5, YS101 carrying pLAFR5, YS101 carrying
pLAFR-ilpA [8], and YS101 carrying pilpA[1-169]) were grown at 30°C in LBS
broth with 2 g/ml tetracycline. At an OD600 of 0.7, the expression of IlpA
protein was induced with 1 mM IPTG for 3 h. Monolayers of INT-407 cells were
then inoculated in triplicate with 50 l of the diluted bacteria to give an MOI of
10 or 50 and were incubated at 37°C in 5% CO2 for 1 to 3 h. The released LDH
activity was then determined by colorimetric assay according to the manufactur-
er’s instructions and is presented as the percentage of LDH activity relative to
the total LDH activity of the cells lysed by a treatment with 1.0% Triton X-100.
Preparation of human PBMCs and cytokine assays. Human peripheral blood
mononuclear cells (PBMCs) were prepared by density gradient centrifugation,
using Ficoll (Amersham Biosciences), and were resuspended in RPMI 1640
medium supplemented with 10% heat-inactivated fetal bovine serum, 100
units/ml penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine. Prepared
PBMCs (1  105 cells per well) were cultured in 96-well plates and then incu-
bated for 18 h with the lysates of various V. vulnificus strains, concanavalin A
(ConA), or bovine serum albumin (BSA) at a concentration of 10 g/ml. The
levels of gamma interferon (IFN-) in the cell-free supernatants were deter-
mined using enzyme-linked immunosorbent assays (BD Biosciences). The con-
centration of IFN- was determined based on the standard curve for commer-
cially available IFN- (BD Biosciences).
Expression and purification of rIlpA protein and its truncated polypeptides.
The full-length IlpA protein was expressed in E. coli by use of an overexpression
plasmid, pET-IlpA (8). A DNA fragment containing the open reading frame
(ORF) of IlpA was dissected into three parts (Fig. 1). The 5 region of ilpA (273
bp) was amplified from the genomic DNA of V. vulnificus ATCC 29307 by a PCR
using the primers rIlpA#1FB (5-CGACGGATCCATGAAATTTAGCCTTAA
AGGTT-3; the underlined region indicates a BamHI restriction site) and
rIlpA#1RH (5-CGCACTCGAGGTAGCCACGGTCTTCC-3; the underlined
region denotes a restriction site for HindIII), and the 3 region of ilpA (303 bp)
was amplified with another set of primers, rIlpA#3FB (5-CGACGGATCCTC
TATCAACCTAACTCCGG-3; the underlined region indicates a restriction site
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristics Source or reference
Strains
E. coli strains
DH5 supE44 lacU169 (	80dlacZM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Invitrogen
SM10 pir thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu pir, OriT of RP4, Kmr; conjugational
donor
31
BL21(DE3) F
 dcm ompT hsdS (rB

 mB

) gal (DE3) Invitrogen
JM109 endA1 recA1 gyrA96 thi-1 hsdR17(rK

 mK

) relA1 supE44 (lac-proAB) F traD3
6proAB lacIqZM15
Qiagen
V. vulnificus strains
ATCC 29307 Clinical isolate American Type Culture
Collection
YS101 ilpA mutant of ATCC 29307 8
Plasmids
pLAFR5 RP4; derivative of pLAFR3 containing a double cos cassette; Tcr 16
pLAFR-ilpA pLAFR5 with 2,135-bp V. vulnificus ilpA; Tcr 8
pilpA1-169 pLAFR5 with 729-bp V. vulnificus 3-truncated ilpA; Tcr This study
pET-28b Expression vector for a histidine-tagged protein Novagen
pET-IlpA pET-28b with 810-bp ilpA gene 8
pQE-30 Expression vector for a histidine-tagged protein Qiagen
pQE-IlpA#1 pQE-30 with 273-bp ilpA gene (encoding G24 to I114) This study
pQE-IlpA#2 pQE-30 with 333-bp ilpA gene (encoding A115 to Y225) This study
pQE-IlpA#3 pQE-30 with 303-bp ilpA gene (encoding I170 to W269) This study
FIG. 1. rIlpA protein of V. vulnificus and its truncated derivatives
used in this study. Four different rIlpA polypeptides were prepared to
contain the complete IlpA ORF (rIlpA) and the N-terminal
(rIlpA#1), central (rIlpA#2), and C-terminal (rIlpA#3) regions.
Amino acid residues and their positions in each rIlpA polypeptide are
displayed with alphabetical abbreviations and numbers, respectively.
The hatched areas indicate hydrophobic regions of the protein.
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for BamHI) and rIlpA#3RH (5-CCTGCTCGAGTTTCAAATGTGACGACT
GCC-3; the underlined region indicates a HindIII restriction site). The central
part of the ilpA gene, which codes for amino acid residues constituting the major
hydrophobic regions of IlpA, was amplified as a 333-bp DNA fragment, using the
following set of primers: rIlpA#2FB (5-ATGCGGATCCGCGGCATTGGAT
GACGG-3; the underlined region indicates a BamHI site) and rIlpA#2RH
(5-CCTGCTCGAGCGAACGGTCGCAAGTAGG-3; the underlined region
denotes a HindIII site). The resultant ilpA DNA fragments were cloned into
pQE30 (Qiagen) by using restriction sites for BamHI and HindIII to generate a
series of overexpression plasmids for the truncated rIlpA polypeptides (pQE-
IlpA#1, pQE-IlpA#2, and pQE-IlpA#3). These rIlpA polypeptides were ex-
pressed in a histidine-tagged form in E. coli JM109 cells to which 1 mM IPTG
had been added and were purified using nickel-nitrilotriacetic acid affinity chro-
matography as described by the manufacturer (Qiagen).
Ligand-binding immunoblot assay. Each well of a 24-well culture plate was
seeded with 2  105 INT-407 cells and incubated overnight at 37°C in the
presence of 5% CO2. After removal of the medium and two washes with DMEM,
the cells were incubated in 1 ml of serum-free DMEM containing 10 g of the
rIlpA protein (8) as described by Jin et al. (12). After five washes with DMEM,
the cells were disrupted with 70 l of lysis buffer (10 mM Tris-HCl, pH 8.4, and
0.8% SDS) and boiled for 10 min. To examine whether rIlpA was stably bound
to INT-407 cell monolayers, a portion of the lysate (200 g of protein per well)
was subjected to SDS-PAGE and then transferred to a polyvinylidene difluoride
(PVDF) membrane. The membranes were blocked with 5% nonfat dry milk in
TBST (Tris-buffered saline with 0.1% Tween 20) for 1 h at room temperature,
treated with anti-IlpA antibodies (8) at 4°C overnight, and subsequently incu-
bated with alkaline phosphatase (AP)-conjugated anti-rat IgG (Sigma-Aldrich).
To determine the domain of IlpA responsible for binding to host cells, the
ligand-binding immunoblot assays were performed with the three truncated
rIlpA polypeptides tagged with histidine residues, and then the bound polypep-
tide was detected using anti-poly-His monoclonal antibodies (Sigma). Immuno-
reactive bands were visualized by using a nitroblue tetrazolium (NBT) and
5-bromo-4-chloro-3-indolyl phosphate (BCIP) system (Promega).
To monitor the protein levels of INT-407 cells after each treatment, the
INT-407 cell lysates used for the above ligand-binding immunoblot assays were
subjected to SDS-PAGE and then transferred to a PVDF membrane. The mem-
branes were blocked with 5% nonfat dry milk in TBST for 1 h at room temper-
ature, treated with anti-human Cu/Zn superoxide dismutase (Cu/Zn SOD) an-
tibodies (Millipore) at 4°C overnight, subsequently incubated with AP-
conjugated anti-rabbit IgG (Sigma-Aldrich), and then visualized using a kit
containing NBT and BCIP (Promega).
Fluorescence microscopy. Intact rIlpA and three truncated rIlpA polypeptides,
rIlpA#1, rIlpA#2, and rIlpA#3, were conjugated with a fluorescent probe by
use of an Alexa Fluor 555 microscale protein labeling kit (A30007; Molecular
Probes). Briefly, 100 g of recombinant polypeptide was incubated with Alexa
Fluor 555-succinimidyl ester, and then unincorporated probe was removed by
spin filters supplied with the kit. The fluorescence of the proteins at 280 nm and
at 555 nm was measured to ensure appropriate labeling of the recombinant
polypeptides as directed by the manufacturer. INT-407 cells were seeded and
grown on glass coverslips for 24 h. Cells were blocked with 1% BSA for 30 min
in DMEM, followed by a 1 h-treatment with 10 g/ml Alexa Fluor 555-labeled
polypeptides at 37°C. Cells were washed with PBS three times and fixed in 3.7%
paraformaldehyde-PBS at room temperature for 30 min. After being washed
three times with PBS, the coverslips were then mounted on glass slides by use of
a mounting medium that included an antifading agent and sodium azide (fluo-
rescence mounting medium; Dako) and were then observed under a confocal
laser scanning microscope (LSM700; Carl Zeiss MicroImaging). For an assay to
examine the competition of binding to INT-407 cells by intact rIlpA and
rIlpA#3, Alexa Fluor 555-labeled full-length rIlpA (10 g/ml) was mixed with
unlabeled rIlpA#3 at molar ratios of 1:1, 1:5, and 1:10 and then incubated with
INT-407 cells as described above.
Statistical analyses. Results are expressed as means  standard deviations for
three independent experiments. Statistical analysis was performed using analysis
of variance (ANOVA). Differences were judged as statistically significant when
the P value was 0.05. Statistical analysis for pairwise comparisons was per-
formed using Student’s t test (SigmaPlot, version 9; Systat Software Inc.). Dif-
ferences were considered significant if the P values were 0.05.
RESULTS
Role of IlpA protein in cytoadherence of V. vulnificus. V.
vulnificus IlpA was isolated by immunoscreening of an expres-
sion library with antibodies raised against a fraction containing
V. vulnificus OMPs, and it was further identified as an immu-
nogenic protein of this microorganism (8). Some bacterial
OMPs have been reported to have dual functions as adhesins
and immunogens, such as the surface adhesion protein of
Streptococcus pneumoniae (PsaA) (20) and the NadA adhesion
protein of Neisseria meningitidis (6). Thus, in the present study,
we examined in more detail the role of the IlpA protein in the
interactions of V. vulnificus with host cells, particularly in the
adherence of this organism to the human intestinal epithelial
cell line INT-407 (Fig. 2A). When the ratio of bacteria to
INT-407 cells was 10:1, the percentage of adhered wild-type V.
vulnificus carrying pLAFR5, the vector plasmid, was about
10% of the bacteria initially added to the assay mixture. In the
same assay with the ilpA mutant YS101 carrying pLAFR5,
the portion of bacterial cells adhered to INT-407 cells was
significantly lowered, i.e., 2.1% of the added bacteria (P 
0.0026; Student’s t test). However, when YS101 was carrying
pLAFR-ilpA, an lipA-containing plasmid, cytoadherence of
this strain recovered almost (9.7%) to that of the wild type
carrying pLAFR5.
The role of the IlpA protein in cytoadherence of wild-type V.
vulnificus was further confirmed by examining if masking of
IlpA on the bacterial surface with anti-IlpA antibodies inhib-
ited bacterial adherence (Fig. 2B). Wild-type V. vulnificus was
treated for 30 min with various concentrations of anti-IlpA
antibodies (ranging from 10 to 30 g) prior to the adherence
assay. As a control, wild-type V. vulnificus that had been incu-
bated with rat preimmune serum at the same concentrations
was used for the adherence tests. When wild-type V. vulnificus
was preincubated with anti-IlpA antibodies, the levels of cy-
toadherence decreased gradually, in a dose-dependent man-
ner, to 1.1%. Statistical analysis using ANOVA indicated a
significant decrease in bacterial cytoadherence upon incuba-
tion with anti-IlpA antibodies (P 6.2E
08). In contrast, 7.4 to
9.0% of the added V. vulnificus bacteria adhered to the cells
treated with preimmune serum, regardless of the concentra-
tion of IgG. ANOVA showed the absence of a meaningful
difference in this set of data (P  0.75). The blocking effect of
anti-IlpA antibodies on bacterial adherence was not derived
from agglutination of bacterial cells in the presence of anti-
IlpA antibodies (data not shown).
Role of IlpA protein in cytotoxicity of V. vulnificus to INT-
407 cells. We examined whether a deficiency of IlpA affects the
ability of V. vulnificus to lyse INT-407 cells. After INT-407 cells
were incubated with either the wild type carrying pLAFR5 or
V. vulnificus ilpA carrying pLAFR5 at two different MOIs, 10
and 50, the viability of the INT-407 cells was monitored for 3 h
by measuring released LDH (Fig. 3). When INT-407 cells were
treated with wild-type V. vulnificus carrying pLAFR5 at an
MOI of 10, the percentages of released LDH increased grad-
ually, to 95% lysis, as the incubation time extended to 3 h.
When INT-407 cells were exposed to the larger number of
wild-type V. vulnificus cells, i.e., an MOI of 50, they were
completely lysed during 2 h of incubation. In contrast, cytotox-
icity of the ilpA mutant carrying pLAFR5 was estimated to be
significantly lower than that of the wild type at both MOIs (P
0.01; Student’s t test), except for the 3-h incubation at an MOI
of 50 (Fig. 3B), which was not different from the other incu-
bations (P  0.59; ANOVA).
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In subsequent experiments, we examined whether a loss of
cytotoxicity in the ilpA mutant could be recovered by intro-
ducing a complementation plasmid, pLAFR-ilpA. Inclusion of
a complementation plasmid in the ilpA mutant increased
LDH activity up to that of the wild type carrying the vector
plasmid (P  0.05; Student’s t test).
Direct binding of rIlpA to INT-407 cells. We then investi-
gated whether the IlpA protein binds directly to host cells.
INT-407 cells were incubated with rIlpA, washed, and then
prepared as lysates. Western blot analysis of these lysates with
anti-rIlpA antibodies clearly showed that the rIlpA protein was
stably bound to INT-407 cells (Fig. 4A). As a loading control,
the amount of human Cu/Zn SOD in the INT-407 cell lysates
used for this assay was also monitored (17). Figure 4B shows a
similar level of human Cu/Zn SOD in each sample, suggesting
that the absence of immunoreactive bands in Fig. 4A, lane 2,
was not due to a difference in the amounts of human cell
lysates loaded on PAGE gels.
Localization of the cytoadherence domain of the IlpA pro-
tein. An in silico analysis of the amino acid sequence of IlpA
revealed major hydrophobic regions, which may be localized
within the membrane and connect the extracellular, lipidated
N-terminal region and the putatively extracellular C-terminal
region (Fig. 1) (http://www.expasy.ch/tools/protscale.html).
Therefore, the whole ilpA gene was divided into three parts, as
shown in Fig. 1, and cloned into an expression vector; the
N-terminal hydrophilic, central hydrophobic, and C-terminal
hydrophilic regions of IlpA were made as truncated and histi-
dine-tagged forms and were named rIlpA#1, rIlpA#2, and
rIlpA#3, respectively. Truncated rIlpA polypeptides were ex-
amined for the ability to specifically adhere to INT-407 cells
(Fig. 5A). Only the rIlpA#3 polypeptide, containing the C-
terminal domain, was clearly observed in INT-407 cell lysates.
In contrast, the other two rIlpA polypeptides, rIlpA#1 and
rIlpA#2, were not detected in INT-407 cell lysates. In the same
manner, the amount of human Cu/Zn SOD in the INT-407 cell
lysates was detected as a loading control for each sample (Fig.
5B) and indicated that similar amounts of human cell lysates
were used in this study.
Binding of truncated rIlpA polypeptides to INT-407 cells
was directly visualized using a fluorescence microscope (Fig.
6A). Three truncated rIlpA polypeptides were labeled by a red
fluorescent probe, Alexa Fluor 555, and fluorescent recombi-
nant polypeptides were then added to INT-407 cells. Only the
rIlpA#3-treated cells demonstrated fluorescence on the host
cells, whereas INT-407 cells incubated with the other two rIlpA
polypeptides did not show any fluorescence signal.
Full-length rIlpA protein was labeled with a fluorescent
probe and used for the binding experiments. The results dem-
onstrated that the intact IlpA protein binds to INT-407 cells, as
shown in the binding assay with rIlpA#3 (Fig. 6B, panel a). To
confirm the specificity of IlpA binding to INT-407 cells, the
binding reaction mixture containing fluorescent rIlpA protein
and INT-407 cells was examined with various amounts of un-
labeled rIlpA#3 added, from 10 to 100 g (Fig. 6B, panels c,
e, and g). Fluorescent signals on INT-407 cells gradually dis-
appeared as the added amount of rIlpA#3 increased. Addition
of unlabeled rIlpA#1 or rIlpA#2 did not affect the degree of
rIlpA binding to INT-407 cells (data not shown). These two
independent experiments clearly demonstrated that IlpA di-
FIG. 2. Effects of ilpA mutation and exogenously added anti-IlpA
antibodies on adherence of V. vulnificus to INT-407 cells. (A) Cytoad-
herence of various strains of V. vulnificus to INT-407 cells. V. vulnificus
cells (wild-type V. vulnificus ATCC 29307 carrying pLAFR5 [white
bar], ilpA mutant YS101 carrying pLAFR5 [black bar], YS101 carry-
ing a complementation plasmid, pLAFR-ilpA [hatched bar], and
YS101 carrying pilpA[1-169] [gray bar]) were added to INT-407 cells at
an MOI of 10 and incubated for 30 min. The percentage of bacterial
cells adhered to INT-407 cells was determined by measuring the CFU
of the retrieved bacteria. Adherence assays with various V. vulnificus
strains and INT-407 cells were performed in triplicate, and data are
presented as averages with standard deviations. Two asterisks indicate
binding levels that were significantly (P  0.01; Student’s t test) dif-
ferent from that of wild-type V. vulnificus carrying pLAFR5. ANOVA
on this set of data indicated a statistically significant difference (P 
0.00027). (B) Inhibition of cytoadherence of wild-type V. vulnificus to
INT-407 cells by exogenous addition of anti-IlpA antibodies. Prior to
the cytoadherence test, wild-type V. vulnificus was treated for 30 min
with various concentrations of anti-rIlpA antibodies (10, 20, and 30
g/ml) (white bars) or with rat preimmune serum (black bars). The
percentage of bacterial cells that adhered to INT-407 cells was deter-
mined as described above. Two asterisks indicate binding levels that
were significantly different from that of untreated wild-type V. vulnifi-
cus (P  0.01; Student’s t test). Data using anti-IlpA demonstrated a
significant difference (P  6.2E
08; ANOVA), whereas data with IgG
did not indicate any significant difference (P  0.75; ANOVA).
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rectly binds to the surfaces of INT-407 cells via its C-terminal
region, which functions as an adhesin domain.
Role of the C-terminal region of IlpA in pathogenesis of V.
vulnificus. In a previous report (8), the ilpA mutant was dem-
onstrated to be attenuated in virulence. This mutant stimu-
lated less cytokine production from monocytes due to the ab-
sence of the lipidated N terminus of IlpA. In the present study,
it was also shown that the C-terminal region of IlpA plays an
important role in cytoadherence. To dissect the factor causing
virulence attenuation of the ilpA mutant, the phenotypes of
the ilpA mutant carrying pilpA[1-169], in which a C-termi-
nally truncated IlpA polypeptide was produced, were analyzed
(data not shown). This strain showed a similar level of adher-
ence of INT-407 cells (1.7%) to that shown by the ilpA mu-
FIG. 3. Effect of ilpA mutation on cytotoxicity of V. vulnificus to INT-407 cells. Using a CytoTox96 assay kit, the LDH activity released from
lysed INT-407 cells was measured after exposure of cells to various V. vulnificus strains (wild-type V. vulnificus ATCC 29307 carrying pLAFR5
[white bar], ilpA mutant YS101 carrying pLAFR5 [black bar], YS101 carrying a complementation plasmid, pLAFR-ilpA [hatched bar], and YS101
carrying pilpA[1-169] [gray bar]). INT-407 cells (1  105) were incubated with V. vulnificus for various times (1, 2, and 3 h) at MOIs of 10 (A) and
50 (B). Data are means with standard deviations for three independent experiments. Two asterisks indicate LDH activity that was significantly
different (P  0.01; Student’s t test) from that of the wild type carrying pLAFR5. ANOVA on bacterial cytotoxicity for 1, 2, and 3 h of incubation
at an MOI of 10 indicated statistically significant differences (P  1.1E
05, 1.4E
06, and 5.0E
05, respectively). Cytotoxicity data for 1 and 2 h of
incubation at an MOI of 50 also demonstrated significant differences (P 1.1E
09 and 6.2E
06, respectively), whereas 3 h of incubation at an MOI
of 50 did not show any difference by ANOVA (P  0.59).
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tant carrying pLAFR5 (2.1%) (Fig. 2A). This result confirmed
the important role of the C-terminal region of IlpA in cytoad-
herence, as shown in Fig. 5 and 6.
Next, we examined if the C-terminal region is also involved
in stimulation of proinflammatory cytokine production in hu-
man PBMCs. When human PBMCs were treated with a lysate
of the wild type carrying pLAFR5, the secretion of IFN- by
PBMCs was 93 pg/ml (Fig. 7). In contrast, treatment of PBMCs
with a lysate of the ilpA mutant carrying pLAFR5 resulted in
a significantly lowered level of IFN- production (4 pg/ml)
(P  0.044; Student’s t test), which was comparable to those of
the control cells, such as PBMCs treated with medium only or
with BSA. When a lysate of the ilpA mutant carrying pLAFR-
ilpA was used to challenge PBMCs, IFN- production was
restored to the level induced by wild-type V. vulnificus lysate
(69 pg/ml) (P  0.47; Student’s t test). Lysates of the ilpA
mutant carrying pilpA[1-169] were effective at inducing cyto-
kine production by human PBMCs (56 pg/ml), showing similar
levels to those shown by the wild type carrying the vector and
the ilpA mutant carrying pLAFR-ilpA (P  0.32 and 0.38,
respectively). Human PBMCs treated with ConA, which served
as a positive control for this experiment, showed IFN- pro-
duction at 79 pg/ml. The capacity of the amino-terminal do-
main to reproduce most of the immunostimulating activity of
IlpA suggests that the C-terminal domain of IlpA may not have
a major role in immunostimulating activity of IlpA.
Since the plasmid encoding the C-terminally deleted IlpA,
pilpA[1-169], was found to be defective in recovery of cytoad-
herence of the ilpA mutant (Fig. 2A) but efficient in recovery
of immunostimulation of the ilpA mutant (Fig. 7), we further
examined whether this truncated IlpA was involved in bacterial
cytotoxicity to INT-407 cells. The ilpA mutant carrying
pilpA[1-169] exhibited lowered levels of cytotoxicity, 27 to 57%
of those of the wild type carrying the vector plasmid, except for
the 3-h incubation at an MOI of 50 (Fig. 3). Therefore, all of
the results for the ilpA mutant carrying pilpA[1-169] suggest
that decreased cytotoxicity of the ilpA mutant was caused
mainly from reduced cytoadherence.
DISCUSSION
The severe and rapid cytopathological characteristics of V.
vulnificus infection have led to this organism being considered
a model system with which to investigate host-pathogen inter-
actions. Among various virulence-related phenotypes, the abil-
ity of bacterial cells to adhere to host cells via bacterial ad-
hesins is critical for the initial pathogenic interaction. The
significant decrease in cytoadherence of a V. vulnificus ilpA
mutant to INT-407 human cells suggests a potential role of the
IlpA protein as an adhesin for this pathogenic microorganism.
The role of IlpA in adherence of V. vulnificus to human
intestinal epithelial cells, such as INT-407 cells, was clearly
demonstrated by comparative cytoadherence assays of wild-
FIG. 4. Determination of binding of rIlpA to INT-407 cells by a
ligand-binding immunoblot assay. (A) Binding of rIlpA to INT-407
cells. INT-407 cells (2  105) were incubated with 10 g rIlpA, and the
cell lysate was analyzed to see if INT-407 cells were bound by added
bacterial proteins via Western blotting using anti-IlpA antibodies.
(B) Loading control. The same INT-407 cell lysates were also analyzed
for their contents of Cu/Zn SOD via Western blotting using specific
antibodies, as described in Materials and Methods. Lanes 1, protein
size marker; lanes 2, INT-407 cells alone; lanes 3, INT-407 cells with
rIlpA; lane 4, rIlpA alone (0.1 g).
FIG. 5. Determination of binding region of IlpA via ligand-binding
immunoblot assay, using truncated rIlpAs and INT-407 cells. INT-407
cells (2  105) were incubated with 10 g of three truncated IlpA
polypeptides, rIlpA#1, rIlpA#2, and rIlpA#3, as shown in Fig. 1.
(A) Cell lysates were then analyzed to see if they were bound by added
polypeptides via Western blotting using anti-His antibodies. Lane 1,
protein size marker; lane 2, INT-407 cells with rIlpA#1; lane 3, INT-
407 cells with rIlpA#2; lane 4, INT-407 cells with rIlpA#3; lane 5,
rIlpA#1 alone (0.1 g); lane 6, rIlpA#2 alone (0.1 g); lane 7,
rIlpA#3 alone (0.1 g). (B) As a loading control, the same INT-407
cell lysates were also analyzed for their Cu/Zn SOD content via West-
ern blotting using specific antibodies, as described in Materials and
Methods.
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type and ilpA mutant V. vulnificus (Fig. 2A). In addition, a
ligand-binding immunoblot assay using rIlpA (Fig. 4A) and
microscopic observation using a fluorescent rIlpA (Fig. 6B)
demonstrated an association of rIlpA with INT-407 cells. As a
result of reduced adherence, the mutant exhibited significantly
less cytotoxicity than the wild type (Fig. 3).
IlpA has previously been reported to be an immunogenic
protein of V. vulnificus which stimulates cytokine production in
human blood cells (8). The V. vulnificus IlpA protein is pre-
sumed to be modified by acylation of its first cysteine residue
with fatty acid chains after its N-terminal leader peptide of 22
amino acid residues is processed. Its lipid moiety is essential to
activate the TLR2-mediated signaling pathway and then to
trigger cytokine production by human monocytes. Therefore,
the IlpA protein may play important roles in V. vulnificus
pathogenicity via at least dual functions during the initial in-
teractions of bacteria with host cells, i.e., cytoadherence to
intestinal epithelial cells and immunostimulation in mono-
cytes.
Some membrane-bound lipoproteins have been reported to
have multiple functions. One of the best-characterized adhe-
sin/immunogen proteins is the 33-kDa PsaA protein of S. pneu-
moniae, which directly binds to the target host cells, such as
nasopharyngeal epithelial cells (9, 23, 29). Mutation in the
psaA gene caused pleiotropic effects on the growth, oxidative
stress response, adherence, and virulence of S. pneumoniae
(14). PsaA was also found to be one of the main pneumococcal
antigens and causes a distinct immune response in a mouse
model which is different from those mediated by other pneu-
mococcal antigens (25). Another group of well-known bacte-
rial adhesins are pili or fimbriae (28). The thin-curled fimbriae
of Salmonella enterica and the fimbrillin of Porphyromonas
gingivalis are able to trigger cytokine production from human
cells via the action of TLR2 (10, 33). Therefore, many mem-
brane-bound lipoproteins as well as surface proteins of diverse
bacteria play multiple roles, and the IlpA protein of V. vulni-
ficus may be added to the list of bacterial proteins performing
at least two distinct roles, facilitating cytoadherence and elic-
iting cytokine production.
Both an in silico analysis of the amino acid sequence of IlpA
and a comparison with the structure of the IlpA homolog
lipoprotein 9 of Staphylococcus aureus (35) allowed us to lo-
FIG. 6. INT-407 cells incubated with rIlpA polypeptides labeled by a fluorescent dye. (A) Binding of truncated rIlpAs to INT-407 cells. INT-407
cells (5  104) incubated with 10 g of Alexa Fluor 555-labeled rIlpA#1 (a and b), rIlpA#2 (c and d), or rIlpA#3 (e and f) were observed under
a laser scanning confocal microscope. The images were collected as serial sections at 0.5-m intervals and analyzed by Zeiss LSM image browser
software (ZEN2009LE; Zeiss). Fluorescent images are presented on the left (a, c, and e), and light micrographs are presented on the right (b, d,
and f). Bars, 50 m. (B) Binding of intact rIlpA to INT-407 cells. INT-407 cells (5  104) incubated with 10 g of Alexa Fluor 555-labeled
full-length rIlpA (a and b) were observed as described above. In addition, the same binding assays were preformed in the presence of 10 (c and
d), 50 (e and f), or 100 g unlabeled rIlpA#3. Fluorescent images are presented on the left (a, c, e, and g), and light micrographs are presented
on the right (b, d, f, and h). Bars, 50 m.
FIG. 7. Cytokine production in human PBMCs induced by V. vulnificus cell lysates. PBMCs (1  105) prepared from human blood were
incubated for 18 h with lysates (10 g/ml) of bacterial strains (wild-type V. vulnificus ATCC 29307 carrying pLAFR5, the ilpA mutant YS101
carrying pLAFR5, YS101 carrying pLAFR-ilpA, and YS101 carrying pilpA[1-169]). The concentrations of IFN- stimulated by lysates, medium
(none), BSA, and ConA were determined using a human IFN- enzyme-linked immunosorbent assay kit (BD Biosciences). Error bars represent
the standard deviations for three independent experiments. IFN- production induced by each lysate of V. vulnificus was measured in triplicate
for each experiment. Data with an asterisk indicate that the IFN- level was significantly different (P  0.05; Student’s t test) from that of the wild
type carrying pLAFR5. ANOVA on this set of data indicated a significant difference (P  0.00087).
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calize the major hydrophobic regions that might reside in the
outer leaflet of the membrane and connect two extracellular
domains, a lipidated N-terminal region and a putatively extra-
cellular C-terminal region (data not shown). Ligand-binding
immunoblot assays using three different truncated rIlpAs (Fig.
5A) showed that the polypeptide rIlpA#3, including the C-
terminal one-third of the IlpA protein, was as efficient in bind-
ing to INT-407 cells as the intact IlpA protein (Fig. 4A). The
direct binding of rIlpA#3 was confirmed by microscopic ob-
servation using fluorescent probe-labeled truncated rIlpAs
(Fig. 6). On the other hand, two other truncated rIlpA
polypeptides, rIlpA#1 and rIlpA#2, did not show any binding
to host cells. Therefore, the extracellular domains of IlpA may
be accessible to interaction with the host cell surface, and some
of the secondary structures in the extracellularly exposed
rIlpA#3 possibly participate in binding to the specific host
receptor, which has not yet been identified.
Using recombinant PsaA protein covalently bound to fluo-
rescent spheres, E-cadherin was identified as a host cellular
receptor for PsaA of S. pneumoniae (1). A Campylobacter jejuni
adhesin, JlpA lipoprotein, was found to trigger inflammatory/
innate immune responses in host cells during C. jejuni infection
via direct interaction with surface-exposed heat shock protein
90 and subsequent activation of NF-B and p38 mitogen-
activated protein (MAP) kinase in host cells (13). A family of
opacity outer membrane proteins (Opa proteins) plays a sig-
nificant role during cytoadherence of Neisseria gonorrhoeae to
human cells (20). Their interaction with host cells is mediated
by several cellular components, including heparin sulfate pro-
teoglycan, extracellular matrix components, and CD66 family
receptors (4). Interaction between Opa and these host compo-
nents activates a signaling pathway resulting in transcellular
transversal of this pathogen across human cells (34).
In addition to IlpA, two adhesins have been documented for
V. vulnificus, including OmpU (7) and PilA (26). Further in-
vestigation using V. vulnificus strains deficient in multiple loci
of these adhesin genes will be needed to evaluate the contri-
bution of each adhesin to overall cytoadherence of V. vulnificus
to diverse cell types. Due to a lack of this information, it is
premature to suggest that each adhesin functions with a spe-
cific cell type or broad range of cell types. Human epidermoid
carcinoma (HEp-2) cells were used for studies of OmpU (7)
and PilA (26), whereas the INT-407 cell line, derived from
human intestinal epithelial cells, has been used for IlpA. How-
ever, the effects of ilpA mutation on adherence and cytotoxicity
are not confined to the specific host cell line used in this study,
since the same effects were also observed in similar experi-
ments using HEp-2 cells (Y.-S. Han, S.-J. Park, and K.-H. Lee,
unpublished data). Fibronectin, especially its RGD repeat, was
found to be a receptor for the OmpU protein in V. vulnificus
(7) as well as in Vibrio cholerae (32). However, no information
is available on a receptor for V. vulnificus PilA.
Among the three adhesins of V. vulnificus, only IlpA has
been shown to stimulate the production of proinflammatory
cytokines in human monocytes. However, the possibility that
the other adhesins of V. vulnificus have immunostimulating
activity cannot be excluded. A V. cholerae ompU mutant was
defective in activation of a proinflammatory response (2), and
the V. vulnificus outer membrane protein fraction, including
OmpU, was effective at eliciting immunization of mice against
V. vulnificus (15). In addition, a Pseudomonas aeruginosa pilA
mutant induced less secretion of cytokines and showed a lack
of neutrophil chemotaxis in a murine model (22).
As mentioned above, IlpA stimulates cytokine production
from human blood cells, and TLR2 of the host cells is a critical
component for this process (8). A direct association between
IlpA and TLR2 has not been proven and needs to be verified
by further investigation. Similarly, further study is required to
identify the host receptor molecule(s) for the adhesion domain
of IlpA and to elucidate subsequent signaling processes in host
cells. Therefore, we are currently screening for a host recep-
tor(s) for V. vulnificus IlpA. The study of adhesin-receptor
interactions will elucidate the complex interactive networks of
diverse adhesins of V. vulnificus during the initial pathogenicity
process, in which each adhesin might interact with unique or
common receptor molecules to efficiently connect the required
steps for successful cytoadherence to and entry into specific
cell types.
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